CBD Global Sciences EPS
What is the EPS of CBD Global Sciences?
The EPS of CBD Global Sciences Inc. is -0.55
What is the definition of EPS?
Earnings per share (EPS) is the portion of a company’s profit allocated to each outstanding share of common stock. It is adjusted for dilution and calculated over trailing twelve months.
ttm (trailing twelve months)
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS of companies in the Health Care sector on OTC compared to CBD Global Sciences
What does CBD Global Sciences do?
CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers provides biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.
Companies with eps similar to CBD Global Sciences
- Fortem Resources has EPS of -0.55
- Mercell AS has EPS of -0.55
- CCT Fortis has EPS of -0.55
- CareRx has EPS of -0.55
- Sysco has EPS of -0.55
- Afterpay Touch has EPS of -0.55
- CBD Global Sciences has EPS of -0.55
- Nephros has EPS of -0.55
- Nephros has EPS of -0.55
- Nephros has EPS of -0.55
- VM Hotel Acquisition Corp has EPS of -0.55
- DEMIRE Deutsche Mittelstand Real Estate AG has EPS of -0.55
- Vestas Wind Systems A/S has EPS of -0.55